Tylenol Faces Legal Heat Over Pregnancy Concerns

Texas Takes Legal Action Texas has taken a bold step by suing Tylenol's maker, Kenvue, and its former owner, Johnson & Johnson. The lawsuit claims these companies misled the public about Tylenol's safety during pregnancy. The main concern? A possible link between Tylenol and developmental issues like autism and ADHD.

The Lawsuit's Claims

The lawsuit, filed in Texas, argues that the companies knew about potential risks but kept selling the product anyway. This is a serious accusation, but it's important to note that the FDA hasn't confirmed a direct link. They're currently reviewing the evidence and might update Tylenol's labeling to include a caution about prenatal use.

Kenvue and Johnson & Johnson Respond

Kenvue, however, stands by their product. They insist Tylenol is safe when used as directed and that it's the safest option for pain relief during pregnancy. Johnson & Johnson, which split from Kenvue in 2023, points out that Kenvue now handles all Tylenol-related matters.

Previous Lawsuits and Current Debate

This isn't the first time Tylenol has faced such claims. Earlier lawsuits made similar arguments but were dismissed due to unreliable expert testimony. Those cases are now on appeal.

Advocacy groups are pushing for clearer warnings on Tylenol products. They want the FDA to include information about potential risks for autism and ADHD. Kenvue, however, disagrees. They believe the current evidence doesn't support such warnings.

The Future of Tylenol

The debate continues, and the FDA's decision could have big implications. Until then, pregnant women might want to discuss pain management options with their healthcare providers.